Global Information
회사소개 | 문의 | 비교리스트

아시아태평양의 인공장기 및 생체공학 시장 : 예측과 기회(-2025년)

APAC Artificial Organs and Bionics Market By Products, By Technology, By Material, By End-User, By Country, Forecast & Opportunities, 2025

리서치사 TechSci Research
발행일 2020년 05월 상품 코드 938716
페이지 정보 영문 87 Pages
가격
US $ 3,950 ₩ 4,528,000 Unprintable PDF and Excel (Single User License)
US $ 4,950 ₩ 5,675,000 PDF and Excel (Multi-User License)
US $ 8,950 ₩ 10,261,000 PDF and Excel (Custom Research License)

TechSci Research 보고서는 10% Customization 서비스가 포함되어 있습니다. 보고서에 포함돼 있지 않은 리서치 데이터와 시장 동향을 추가적으로 요청할 수 있습니다. 자세한 사항은 문의하여 주시기 바랍니다.



아시아태평양의 인공장기 및 생체공학 시장 : 예측과 기회(-2025년) APAC Artificial Organs and Bionics Market By Products, By Technology, By Material, By End-User, By Country, Forecast & Opportunities, 2025
발행일 : 2020년 05월 페이지 정보 : 영문 87 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

아시아태평양의 인공장기 및 생체공학 시장은 예측기간 동안 강력한 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

아시아태평양의 인공장기(Artificial Organs) 및 생체공학(Bionics) 시장을 부문별·국가별로 조사했으며, 시장 규모 및 시장 점유율 예측, 촉진요인과 과제, 시장 동향, 경쟁 상황, 기업 개요 등의 정보를 전해드립니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 개요

제4장 고객의 견해

제5장 아시아태평양의 인공장기 및 생체공학 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 제품별(인공 심장, 인공 신장, 인공 갑상선, 인공 다리(Bionic Limb), 인공 와우(Ear Bionic), 인공 폐, 인공 자궁 등)
    • 기술별(Suction Technology, Implanted myoelectric sensor (IMES) technology, Socket-Based Technology, 3D 바이오 프린팅 등)
    • 재료별(기계(플라스틱, 금속), 생체기계(생물 및 고분자), 생물학적)
    • 최종사용자별(병원, 수술센터 등)
    • 기업별
    • 국가별
  • 시장 매력 지수
  • 아시아태평양 : 국가 분석
    • 중국
    • 인도
    • 일본
    • 한국
    • 싱가포르
    • 호주

제6장 시장 역학

  • 성장 촉진요인
  • 과제

제7장 시장 동향과 발전

제8장 경쟁 상황

  • 경쟁 전망
  • 주요 기업 개요
    • Medtronic
    • Getinge AB
    • Ekso Bionics Holdings Inc.
    • Boston Scientific Corporation
    • A biomed
    • Rex Bionics
    • Ossur
    • ReWalk
    • Cyberdyne Inc.
    • Blatchford
    • Obara Kogyo Inc. Ltd.
    • Artificial Limbs Manufacturing Corporation of India
    • Otto Bock
    • Jarvik Heart
    • SynCardia Systems
    • Zimmer Biomet
    • Cochlear Limited
    • Roche Holding AG
    • Gembro AB
    • Lifenet Health

제9장 전략적 권장사항

제10장 면책조항

LSH 20.06.19

The market for artificial organs and bionics in APAC is expected to grow at a robust CAGR during the forecast period. Rising organ failures and increasing cases of disabilities call for the replacement of the damaged part or organ. Additionally, technological advancements have led to the development of the R&D segment and eventually made it easier to replace any damaged or missing organs, which is propelling the growth of the APAC artificial organs and bionics market. However, the market might witness restraints due to the cost expensiveness and scarcity of desired organs.

APAC artificial organs and bionics market can be segmented on the basis of product, technology, material, end-user, company and country. The product segment is further divided into artificial heart, artificial kidney, artificial thyroid gland, bionic limb, ear bionic, artificial lung, artificial womb and others. Artificial kidneys held the dominant share in 2019, on account of increasing renal diseases. Kidney failure leads to incompetent filtration of blood, which calls for kidney replacement, eventually increasing the market share for artificial kidneys segment. Based on country, Japan holds the maximum share of the market in the entire APAC as it is developed enough to carry out transplantations with the assistance of their professional doctors and staff.

Major players in the artificial organs and bionics market of APAC include Medtronic, Getinge AB, Ekso Bionics Holdings Inc., Boston Scientific Corporation, A biomed, Rex Bionics, Ossur, ReWalk, Cyberdyne Inc., Blatchford, Obara Kogyo Inc. Ltd., Artificial Limbs Manufacturing Corporation of India, Otto Bock, Jarvik Heart, SynCardia Systems, Zimmer Biomet, Cochlear Limited, Roche Holding AG, Gembro AB, Lifenet Health, etc. Collaboration and mergers with medical schools or research organizations is one of the key strategies of the companies to sustain and maintain their position in such highly competitive environment.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study:

  • To analyze and forecast the market size of APAC artificial organs and bionics market.
  • To classify and forecast APAC artificial organs and bionics market based on product, technology, material, end-user, company and country.
  • To identify drivers and challenges for APAC artificial organs and bionics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in APAC artificial organs and bionics market.
  • To conduct pricing analysis for APAC artificial organs and bionics market.
  • To identify and analyze the profile of leading players operating in APAC artificial organs and bionics market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals and surgical centers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals and surgical centers which could not be identified due to the limitations of secondary research. TechSci Research analyzed hospitals and surgical centers and presence of all major players across the globe.

TechSci Research calculated the market size of APAC artificial organs and bionics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Hospitals, surgical centers, organ banks/distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to artificial organs and bionics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals and surgical centers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, APAC artificial organs and bionics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Products:

Artificial Heart

Artificial Kidneys

Artificial Thyroid Gland

Bionic Limb

Ear Bionic

Artificial Lung

Artificial Womb

Others

  • Market, By Technology:

Suction Technology

Implanted myoelectric sensor (IMES) technology

Socket-Based Technology

3D Bioprinting

Others

  • Market, By Material:

Mechanical

  • Plastics
  • Metal

Biomechanical

  • Living matter
  • Polymer

Biological

  • Market, By End User:

Hospitals

Surgical Centers

Others

  • Market, By Country:

China

India

Japan

South Korea

Singapore

Australia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in APAC artificial organs and bionics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. APAC Artificial Organs and Bionics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Products (Artificial heart, Artificial Kidneys, Artificial Thyroid Gland, Bionic Limb, Ear Bionic, Artificial Lung, Artificial Womb and Others)
    • 5.2.2. By Technology (Suction Technology, Implanted myoelectric sensor (IMES) technology, Socket-Based Technology, 3D Bioprinting and Others)
    • 5.2.3. By Material (Mechanical (Plastics, Metal), Biomechanical (Living matter and polymer), Biological)
    • 5.2.4. By End-User (Hospitals, Surgical Centers and Others)
    • 5.2.5. By Company (2019)
    • 5.2.6. By Country
  • 5.3. Market Attractiveness Index
  • 5.4. APAC: Country Analysis
    • 5.4.1. China Artificial Organs and Bionics Market Outlook
      • 5.4.1.1. Market Size & Forecast
        • 5.4.1.1.1. By Value
      • 5.4.1.2. Market Share & Forecast
        • 5.4.1.2.1. By Products
        • 5.4.1.2.2. By Technology
        • 5.4.1.2.3. By Material
        • 5.4.1.2.4. By End-User
    • 5.4.2. India Artificial Organs and Bionics Market Outlook
      • 5.4.2.1. Market Size & Forecast
        • 5.4.2.1.1. By Value
      • 5.4.2.2. Market Share & Forecast
        • 5.4.2.2.1. By Products
        • 5.4.2.2.2. By Technology
        • 5.4.2.2.3. By Material
        • 5.4.2.2.4. By End-User
    • 5.4.3. Japan Artificial Organs and Bionics Market Outlook
      • 5.4.3.1. Market Size & Forecast
        • 5.4.3.1.1. By Value
      • 5.4.3.2. Market Share & Forecast
        • 5.4.3.2.1. By Products
        • 5.4.3.2.2. By Technology
        • 5.4.3.2.3. By Material
        • 5.4.3.2.4. By End-User
    • 5.4.4. South Korea Artificial Organs and Bionics Market Outlook
      • 5.4.4.1. Market Size & Forecast
        • 5.4.4.1.1. By Value
      • 5.4.4.2. Market Share & Forecast
        • 5.4.4.2.1. By Products
        • 5.4.4.2.2. By Technology
        • 5.4.4.2.3. By Material
        • 5.4.4.2.4. By End-User
    • 5.4.5. Singapore Artificial Organs and Bionics Market Outlook
      • 5.4.5.1. Market Size & Forecast
        • 5.4.5.1.1. By Value
      • 5.4.5.2. Market Share & Forecast
        • 5.4.5.2.1. By Products
        • 5.4.5.2.2. By Technology
        • 5.4.5.2.3. By Material
        • 5.4.5.2.4. By End-User
    • 5.4.6. Australia Artificial Organs and Bionics Market Outlook
      • 5.4.6.1. Market Size & Forecast
        • 5.4.6.1.1. By Value
      • 5.4.6.2. Market Share & Forecast
        • 5.4.6.2.1. By Products
        • 5.4.6.2.2. By Technology
        • 5.4.6.2.3. By Material
        • 5.4.6.2.4. By End-User

6. Market Dynamics

  • 6.1. Drivers
  • 6.2. Challenges

7. Market Trends & Developments

8. Competitive Landscape

  • 8.1. Competition Outlook
  • 8.2. Players Profiled (Leading Companies)
    • 8.2.1. Medtronic
    • 8.2.2. Getinge AB
    • 8.2.3. Ekso Bionics Holdings Inc.
    • 8.2.4. Boston Scientific Corporation
    • 8.2.5. A biomed
    • 8.2.6. Rex Bionics
    • 8.2.7. Ossur
    • 8.2.8. ReWalk
    • 8.2.9. Cyberdyne Inc.
    • 8.2.10. Blatchford
    • 8.2.11. Obara Kogyo Inc. Ltd.
    • 8.2.12. Artificial Limbs Manufacturing Corporation of India
    • 8.2.13. Otto Bock
    • 8.2.14. Jarvik Heart
    • 8.2.15. SynCardia Systems
    • 8.2.16. Zimmer Biomet
    • 8.2.17. Cochlear Limited
    • 8.2.18. Roche Holding AG
    • 8.2.19. Gembro AB
    • 8.2.20. Lifenet Health

9. Strategic Recommendations

10. About Us & Disclaimer

Back to Top
전화 문의
F A Q